Intravenous ceftriaxone and calcium in the neonate: Assessing the risk for cardiopulmonary adverse events

Pediatrics

Volumn 123, Issue 4, 2009, Pages

  Bradley, John S ^a,d   Wassel, Ronald T ^b   Lee, Lucia ^c   Nambiar, Sumathi ^b  

^a RADY CHILDREN'S HOSPITAL   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^d NONE   (United States)

Author keywords

Calcium; Cardiopulmonary arrest; Ceftriaxone; Drug therapy adverse event; Newborn

Indexed keywords

ALBUMIN; AMIKACIN; AMOXICILLIN; CEFTRIAXONE; FLUMAZENIL; FUROSEMIDE; GENTAMICIN; GLUCONATE CALCIUM; JOSAMYCIN; METRONIDAZOLE; PHYTOMENADIONE; ANTIINFECTIVE AGENT;

ARTICLE; AUTOPSY; CARDIOPULMONARY INSUFFICIENCY; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG FATALITY; DRUG MEGADOSE; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; GROUPS BY AGE; HUMAN; HUMAN TISSUE; INFANT; MORTALITY; NEWBORN; PRIORITY JOURNAL; RISK ASSESSMENT; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; HEART ARREST; INTRAVENOUS DRUG ADMINISTRATION; TOTAL PARENTERAL NUTRITION;

ANTI-BACTERIAL AGENTS; CALCIUM GLUCONATE; CEFTRIAXONE; DRUG THERAPY, COMBINATION; HEART ARREST; HUMANS; INFANT; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; PARENTERAL NUTRITION, TOTAL;

EID: 65349096726     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-3080     Document Type: Article

References (11)

1. Food and Drug Administration. Information for healthcare professionals Ceftriaxone (marketed as Rocephin). Available at: www.fda.gov/CDER/DRUG/ InfoSheets/HCP/ceftriaxone.htm. Accessed August 3, 2008
2. Food and Drug Administration. Rocephin (ceftriaxone sodium) for injection package label. Available at: www.fda.gov/cder/foi/label/2008/050585s050s060lbl. pdf. Accessed September 26, 2008
3. Available at: http://afssaps.sante.fr/htm/10/filltrpsc/lp061202.pdf. Accessed August 4, 2008
4. Food and Drug Administration. MedWatch. Available at: www.fda.gov/medwatch. Accessed October 1, 2008
5. Food and Drug Administration. Code of Federal Regulations, Title 21, Volume 5. Available at: www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/ CFRSearch.cfm?fr=314.80. Accessed September 26, 2008
6. Burkiewicz JS. Incompatibility of ceftriaxone sodium with lactated Ringer's injection. Am J Health Syst Pharm. 1999;56(4):384 (Pubitemid 29093662)
7. Ceftriaxone. In: Trissel LA, ed. Handbook on Injectable Drugs. 14th ed. Bethesda, MD: American Society of Health-System Pharmacists; 2006:334-342
8. Rudolph AM. Fetal and neonatal pulmonary circulation. Annu Rev Physiol. 1979;41:383-395
9. American Academy of Pediatrics. Escherichia coli and other gram-negative bacilli (septicemia and meningitis in neonates). In: Pickering LK, Baker CJ, Long SS, McMillan JA, eds. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006:288-290
10. Bradley JS, Nelson JD. Antiinfective therapy for newborns. In: 2008-9 Nelson's Pocket Book of Pediatric Antimicrobial Therapy. 17th ed. Buenos Aires, Argentina: ACINDES; 2008;16:22-23
11. Saez-Llorens X, McCracken GH. Perinatal bacterial diseases. In: Feigin RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases. Vol 1. 5th ed. Philadelphia, PA: WB Saunders Co; 2004:929-966